A small-scale experiment of using phage-based probiotic dietary supplement for prevention of E. coli traveler's diarrhea

Bacteriophage. 2015 Jul 24;5(3):e1074329. doi: 10.1080/21597081.2015.1074329. eCollection 2015 Jul-Sep.

Abstract

Traveler's diarrhea (TD) is caused by Escherichia coli in 30% of cases. We have developed a phage cocktail for prophylaxis of TD caused by E.coli, Shigella flexneri, Shigella sonnei, Salmonella enterica, Listeria monocytogenes or Staphylococcus aureus, and investigated its effectiveness against infection caused by the non-pathogenic Lac (-) strain of E.coli K12 C600 in animal and human trials. On the 6th day of both animal and human trials E. coli K12 C600 strain was detected in titer of 104 CFU/g of mice feces and 106 CFU/g of human feces in the control (untreated) groups, while it was not detected in the samples of either of the study (phage-treated) groups. These results have great significance because the original coliphages included in the cocktail have a broad host-range including ETEC, EAEC and EHEC strains which cause severe cases of TD.

Keywords: EAEC; EHEC; ETEC; phage prophylaxis; phage-based probiotic dietary supplement; traveler's diarrhea.